MedPath

Characterization of the Iatrogenic Drug Risk in Elderly Patients With Chronic Pain Who Consult the Pain Assessment and Treatment Centre at the Nimes University Hospital

Completed
Conditions
Iatrogenic Drug Risk
Chronic Pain
Registration Number
NCT04006444
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

Chronic pain may be an additional risk factor for drug iatrogeny due to its management and also drug non-compliance in the geriatric population.

it seems interesting to carry out an inventory of the iatrogenic risk before and after the consultation at the pain centre to enable us to identify the patients most at risk. This study would make it possible to characterize elderly patients with chronic pain, in order to consider, in a future study, setting up a pharmaceutical consultation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • The patient must be affiliated or beneficiary of a health insurance
  • Patient ≥ 65 years old
  • Having an outpatient consultation at the pain centre of the Nîmes University hospital of for chronic pain
  • Available for pharmaceutical consultation about 30 minutes
Exclusion Criteria
  • It is impossible to give information
  • The patient objects to participating in this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evolution of the ADE Geriatric risk score2018

The score is calculated on 10 points based on 3 criteria : number of drugs prescribed, prescription of neuroleptics and the initiation of an anticoagulant prescription less than 3 months old. It classifies patients into 3 risk categories: a low risk level for a score of 0 to 1 point, a medium risk level for a score of 2 to 5 points and a high risk level for a score of 6 to 10 points.

Secondary Outcome Measures
NameTimeMethod
rate of patients with a low, medium or high risk level calculated by ADE Geriatric risk score according to the type of pain2018

The score is calculated on 10 points based on 3 criteria : number of drugs prescribed, prescription of neuroleptics and the initiation of an anticoagulant prescription less than 3 months old. It classifies patients into 3 risk categories: a low risk level for a score of 0 to 1 point, a medium risk level for a score of 2 to 5 points and a high risk level for a score of 6 to 10 points.

Trial Locations

Locations (1)

CHU Nimes

🇫🇷

Nîmes, France

© Copyright 2025. All Rights Reserved by MedPath